Show simple item record

Files in this item

Thumbnail
Name:
Crossman_2017_CATOS_JTD_4922.pdf
Size:
140.1Kb
Format:
PDF
View/Open

The Canakinumab Antiinflammatory Thrombosis Outcome Study trial-the starting gun has fired

Item metadata

dc.contributor.authorCrossman, David
dc.contributor.authorRothman, Alexander
dc.date.accessioned2018-03-01T10:30:08Z
dc.date.available2018-03-01T10:30:08Z
dc.date.issued2017-12
dc.identifier252030169
dc.identifier85eda739-20cc-448b-8573-d3af99d3b662
dc.identifier29312693
dc.identifier85039765563
dc.identifier000419323400062
dc.identifier.citationCrossman , D & Rothman , A 2017 , ' The Canakinumab Antiinflammatory Thrombosis Outcome Study trial-the starting gun has fired ' , Journal of Thoracic Disease , vol. 9 , no. 12 , pp. 4922-4925 . https://doi.org/10.21037/jtd.2017.11.96en
dc.identifier.issn2072-1439
dc.identifier.otherPubMedCentral: PMC5756992
dc.identifier.otherORCID: /0000-0003-4762-8623/work/60196617
dc.identifier.urihttps://hdl.handle.net/10023/12826
dc.descriptionAuthors work in the area has been supported by UK Medical Research Council Experimental Medicine Grant (G0502131), the National Institute for Health Research and a UK Medical Research Council Clinical Research Training Fellowship (AR -MR/K002406/1). AR is supported by a Wellcome Trust Clinical Research Career Development Fellowship 206632/Z/17/Z.en
dc.format.extent4
dc.format.extent143525
dc.language.isoeng
dc.relation.ispartofJournal of Thoracic Diseaseen
dc.subjectRM Therapeutics. Pharmacologyen
dc.subjectT-NDASen
dc.subject.lccRMen
dc.titleThe Canakinumab Antiinflammatory Thrombosis Outcome Study trial-the starting gun has fireden
dc.typeJournal itemen
dc.contributor.institutionUniversity of St Andrews. School of Medicineen
dc.contributor.institutionUniversity of St Andrews. Office of the Principalen
dc.identifier.doi10.21037/jtd.2017.11.96
dc.description.statusPeer revieweden


This item appears in the following Collection(s)

Show simple item record

Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.